HTX-011: Clinical Trials

5 trials of HTX-011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Not yet recruiting 1, Unknown 1

Follow HTX-011: new trials by email Literature Review of HTX-011 trials Research Report on HTX-011

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Zynrelef Versus Adductor Canal Block
ZYNRELEF 400Mg-12Mg Extended-Release Solution, Ultrasound-Guided Adductor Canal Block, Ropivacaine 0.5% Injectable Solution - Knee Osteoarthritis, Arthritis Knee
Phase 4Not yet recruitingUniversity of Miami1202027-01-012026-06-12
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty
HTX-011, ropivacaine , epinephrine , ketorolac diluted in sodium chloride - Total Knee Arthroplasty
Phase 4CompletedMayo Clinic2092022-03-112025-04-27
Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)
HTX-011, Bupivacaine Hydrochloride, MMA regimen - Postoperative Pain, Total Shoulder Arthroplasty
Phase 4CompletedHeron Therapeutics302021-10-202026-10-27
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
Bupivacaine Hydrochloride, HTX-011, Luer lock applicator - Analgesia
Phase 4UnknownHeron Therapeutics902021-10-122023-10-26
Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)
MMA regimen, ZYNRELEF kit components for administration, HTX-011 - Postoperative Pain, Abdominoplasty Surgery
Phase 4CompletedHeron Therapeutics372021-10-122026-10-28

Conditions studied

Pain, Postoperative (3)  ·  Agnosia (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Heron Therapeutics (3)  ·  Mayo Clinic (1)  ·  University of Miami (1)

Countries

United States (5)

Top investigators

Colin A. McNamara, MD,MBA (1)  ·  Matthew P Abdel, MD (1)